Global NewsNews

JB Chemicals gets US FDA nod for allergic rhinitis drug

The company expects to commercialise this product in the first quarter of 2021-22 

The US Food and Drug Administration (US FDA) has approved company’s abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy, JB Chemicals and Pharmaceuticals said in a regulatory filing.

THIS CAN BE YOUR ADVERTISEMENT

JB Chemicals and Pharmaceuticals said it has received approval from the US health regulator to market Loratadine tablets, used to treat allergies, in the American market.

The US FDA has approved company’s abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy, JB Chemicals and Pharmaceuticals said in a regulatory filing.

JB Chemicals’ product is a generic version of Bayer Healthcare’s Clartin tablets.

“The company expects to commercialise this product in the first quarter of 2021-22 and is expected to improve its US sales,” the drug firm noted.

PTI

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close